We identified that both sRANKL levels and sRANKL/OPG ratio can be used as biomarkers of osteoporosis, and an association with the estimated 10-years risk to the major osteoporotic and hip fracture assessed by FRAX in patients with RA was found. This evidence concerns the gene TNFRSF11B and osteoporosis.